Abbott Labs board OKs $7 billion stock buyback program
Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was approved by Abbott’s board of directors this month, the North Chicago-based company announced today in conjunction with revealing its third-quarter earnings.
US companies boosted their stock buyback plans this year, amidrising profits and excess cash. According to data from EPFR, ...
Lower-rated Indian companies and first-time borrowers will benefit the most from the market regulator's recent move that will ...
The board of Ulta Beauty has approved a $3 billion share repurchase authorization as it prepares to open 200 net new stores over the next three years. The specialty cosmetics retailer said Wednesday ...
Asian equities rose as investors digested China’s better-than-expected economic data and stock buyback program details from ...
Buybacks are popular in a hot stock market as concerns about a potential increase to the 1% buyback tax heat up Companies have been feverishly announcing plans to buy back their own stock this ...
The Winnipeg, Manitoba-based packaging solutions said Thursday that the Toronto Stock Exchange has accepted the amendment to increase the maximum number of shares it can repurchase under its current ...
City Hall may have disqualified itself from getting millions in federal housing dollars. Crain’s residential real estate ...
The previously announced program offers 300 billion yuan ($42.1 billion) in low-cost loans to 21 eligible commercial banks ...
Microsoft recently announced a stock buyback and dividend hike. Does this news make MSFT stock a potential buy?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback